Cytel

What Cytel does

Cytel is a privately held, data-science–focused contract research organization (CRO) founded in 1987 and headquartered in Cambridge, Massachusetts. The company serves pharmaceutical, biotechnology, and academic life sciences clients with an integrated offering that combines proprietary statistical software, biostatistics and biometrics services, adaptive trial design expertise, real-world evidence generation, regulatory strategy, and functional service provider (FSP) staffing. Its core software portfolio is anchored by the East Horizon™ Platform for adaptive and Bayesian trial design and simulation, supplemented by the Xact software suite (StatXact®), Enforesys for trial implementation, LiveSLR® for systematic literature reviews, Solara® for complex innovative trial designs, and OKGO® for randomization and patient management. The company also operates Axio®, a wholly owned subsidiary providing data monitoring committee services that facilitate more than 500 DMC meetings annually, and stève consultants for strategic consulting in Europe.

Name

Cytel

Legal name

Cytel Inc.

Website

https://cytel.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Cytel is a data-science CRO that provides adaptive trial design software, biostatistics, real-world evidence, and FSP services to pharmaceutical, biotechnology, and academic life sciences organizations globally.

Ownership category

akta.pro rank

Product category

Clinical Trial Design Software & CRO Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Clinical Trial Management Systems (CTMS) (HLACAOAD), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Clinical research services
• Adaptive trial design
• Biostatistics software
• Real-world evidence
• Contract research organization

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices15 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Functional Service Provider (FSP): Scalable teams of experts integrated into client processes for project delivery across clinical trial phases. Provides flexible staffing and capacity management.
2. Project-Based Analytical Services: Specialized expertise and end-to-end biometrics delivered on a project basis, including strategic consulting, clinical development planning, and regulatory strategy.
3. Software Licensing: Enterprise software platform licenses for trial design, simulation, and implementation. Includes East Horizon, StatXact, Solara, Enforesys, and LiveSLR available through CytelStore.
4. Strategic Consulting: High-value consulting engagements including regulatory strategy, market access, health economics, and clinical development strategy.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Cytel is a data-science CRO that sells proprietary clinical trial design and simulation software (East Horizon, StatXact, Solara, Enforesys, LiveSLR) alongside professional services including adaptive trial design consulting, biostatistics, real-world evidence generation, regulatory strategy, and functional service provider (FSP) staffing for pharmaceutical, biotech, and academic research clients.

Product overview

Cytel is a data-science focused Contract Research Organization (CRO) offering an integrated platform of clinical trial design software and strategic analytics services. The core software portfolio includes the East Horizon™ Platform for AI-enabled adaptive trial design and simulation, the Xact Software Suite (including StatXact®) for exact statistical inference, Enforesys for trial implementation and patient enrollment optimization, and LiveSLR for systematic literature reviews. These are complemented by specialized service offerings including Axio DMC Services (Data Monitoring Committee support), Real-World Evidence Solutions, Strategic Consulting, Functional Service Provider (FSP) staffing, and Project-Based Analytical Solutions. The company operates across global locations including North America (Cambridge MA headquarters, Seattle WA), Europe (Geneva, Basel, Paris, London, Rotterdam, Berlin, Stockholm, Uppsala), India (Pune, Hyderabad), and China (Shanghai, Beijing), with recent expansion into Asia Pacific.

Differentiator

Problem solved

Functional benefit

Brands

• East Horizon™ Platform: Trial design software platform for clinical trial design and simulation
• Xact software suite
• Axio®
• LiveSLR®
• Enforesys
• Solara®
• stève consultants
• OKGO®

Products and services

• East Horizon Platform
• Xact Software Suite (StatXact)
• Enforesys
• LiveSLR
• Axio DMC Services
• OKGO
• Real-World Evidence Solutions
• Strategic Consulting
• Functional Service Provider (FSP)
• Project-Based Analytical Solutions

Quantifiable outcome

• Simulation can reduce active ingredient requirements by over 37% while decreasing medication shipments
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature10 records

Partnerships

One partnership is on record.

• OneMedNetcoreStrategic or Co-development Partner · 22 July 2024Cytel was unveiled as OneMedNet's newest alliance partner. This partnership enables Cytel to leverage OneMedNet's real-world data capabilities to enhance clinical trial design and healthcare decision-making through advanced data sources and analytical methods.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• IQVIA: IQVIA is the world's largest CRO and life sciences analytics provider, offering end-to-end clinical, RWE, and technology services that directly overlap with Cytel's biometrics, FSP, and adaptive trial design capabilities — Cytel competes as a specialized alternative to IQVIA's full-service engagements.
• ICON plc: ICON is a top-3 global CRO with strong biometrics, FSP, and adaptive trial capabilities post-PRA Health Sciences and Symphony Health acquisitions, making it a primary competitor for Cytel's project-based and FSP engagements with pharma/biotech sponsors.
• Labcorp (Covance Drug Development): Labcorp's Covance division is a global full-service CRO offering clinical trial services, central lab, and FSP models that compete head-to-head with Cytel for biometrics and adaptive trial design work, particularly among large pharma clients.
• Pharmaron: Pharmaron is a China-headquartered CRO/CDMO offering integrated drug discovery, clinical, and biostatistics services — comparable to Cytel's end-to-end biometrics and biostatistics services, particularly relevant as Cytel expands in APAC.
• Charles River Laboratories: Charles River provides preclinical and clinical research services including biostatistics and trial design support, overlapping with Cytel's project-based analytics and consulting offerings, though its center of gravity is preclinical.
• Parexel International: Parexel is a global CRO offering biometrics, biostatistics, FSP, and adaptive trial expertise post-its 2021 EQT-led take-private, competing with Cytel for mid-sized biotech and large pharma biometrics engagements.

Direct peers

• Medidata Solutions (Dassault Systèmes): Medidata provides clinical trial technology platforms (Rave EDC, Medidata AI) and competes directly with Cytel's East Horizon and trial implementation software for sponsor design and simulation workflows, though Medidata is more EDC/CTMS-focused while Cytel emphasizes adaptive design.
• Veeva Systems: Veeva's Vault CDMS and Vault CTMS compete with Cytel's clinical trial software, and Veeva's broader life sciences CRM and regulatory solutions overlap with Cytel's RWE and regulatory strategy offerings among pharma sponsors.
• Berry Consultants: Berry Consultants is a specialized statistical consulting firm pioneering adaptive trial design and Bayesian methods — directly comparable to Cytel's core methodological DNA and competing for adaptive trial design consulting engagements.

Emerging players

• Clario: Clario (formed from ERT and Bioclinica) provides clinical trial technology including EDC, eCOA, and imaging with growing AI/biostatistics capabilities — adjacent to Cytel's software stack and competing in some sponsor technology selections.

Market position

Strengths5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/cytel
• LinkedInlinkedin.com/company/cytel
• Facebookfacebook.com/cytel

Revenue estimate

Valuation estimate

Number of profiles

Profiles24 records

Subsidiaries3 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cytel